Pantecta (Pantoprazole)

Pantoprazole, the active ingredient in Pantecta, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid production and is indicated for conditions such as gastro‑oesophageal reflux disease, erosive esophagitis, Zollinger‑Ellison syndrome, and for preventing NSAID‑induced gastric ulcers in adult patients.

GNH USA supplies Pantecta as a licensed, GDP‑compliant international pharmaceutical product serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support global distribution. Customers benefit from reliable supply chains and responsive technical support.

Pantoprazole is a proton pump inhibitor used to manage acid‑related gastrointestinal disorders. - Gastro‑oesophageal reflux disease (GERD): Reduces acid exposure, relieving heartburn and regurgitation. - Erosive esophagitis: Promotes healing of acid‑damaged esophageal tissue. - Zollinger‑Ellison syndrome: Controls excessive gastric acid secretion caused by gastrin‑producing tumors. - Prevention of NSAID‑induced gastric ulcers: Decreases risk of ulcer formation in patients taking non‑steroidal anti‑inflammatory drugs.

Adverse reactions may occur with pantoprazole therapy.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: loose stools, occasional urgency. - Nausea: feeling of stomach upset. - Abdominal pain: cramping or discomfort. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing. - Clostridioides difficile infection: severe colitis with watery diarrhea. - Elevated liver enzymes: signs of hepatic injury. - Hypomagnesemia: low magnesium levels with prolonged use. - Stevens‑Johnson syndrome: severe skin and mucous membrane reaction. - Interstitial nephritis: kidney inflammation presenting with reduced urine output.

Before initiating therapy, consider the following precautions. - Assess renal function: adjust use in severe renal impairment. - Monitor magnesium levels: prolonged treatment may cause hypomagnesemia. - Review concomitant CYP2C19 inhibitors: avoid unless medically necessary. - Use cautiously in hepatic impairment: monitor liver function tests. - Store at ambient temperature: keep in the original container, protect from moisture.

Pantoprazole may interact with several medicines.

Major Interactions (Avoid): - Ketoconazole: reduced absorption of ketoconazole. - Clopidogrel: decreased antiplatelet effect. - Atazanavir: diminished antiviral efficacy.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR. - Methotrexate: heightened toxicity risk. - Digoxin: altered serum concentrations.